Skip to main content
Optomed Oyj logo

Optomed Oyj — Investor Relations & Filings

Ticker · OPTOMED ISIN · FI4000410881 LEI · 7437009IVYWGEE4S7B77 HE Manufacturing
Open in API
Filings indexed 613 across all filing types
Latest filing 2022-12-14 Share Issue/Capital Cha…
Country FI Finland
Listing HE OPTOMED

About Optomed Oyj

https://www.optomed.com/

Optomed is a medical technology company that develops, commercializes, and manufactures handheld fundus cameras and related artificial intelligence (AI) solutions. The company specializes in portable retinal imaging devices designed for the early detection of blinding eye diseases, such as diabetic retinopathy, and other health conditions. Its technology combines portable hardware with AI-powered software to provide real-time analysis and results, enabling comprehensive eye screenings in various healthcare settings, from primary care clinics to emergency rooms. The solutions are designed to integrate into existing clinical workflows, improving access to eye care and transforming routine screenings into comprehensive health assessments.

Recent filings

Filing Released Lang Actions
New shares subscribed for in Optomed Plc's directed share issue have been registered in the Finnish Trade Register
Share Issue/Capital Change Classification · 99% confidence The document is a short stock exchange release (1568 characters) dated December 14, 2022. The content explicitly details the registration of new shares following a directed share issue, the resulting total number of shares (16,541,355), and the admission of these new shares to trading. This directly relates to a change in the company's capital structure via the issuance of new stock. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA). It is not an announcement of a report (RPA/RNS) because it contains the substantive information itself, not just a notice that a report is available.
2022-12-14 English
Sisäpiiritieto: Optomed Oyj toteutti onnistuneesti suunnatun osakeannin keräten 4,1 miljoonaa euroa
Share Issue/Capital Change Classification · 98% confidence The document is an official announcement from Optomed Oyj regarding a successful directed share issue (private placement) to raise 4.1 million euros. It details the number of shares issued, the subscription price, the purpose of the capital raise (strengthening the balance sheet and funding growth), and the regulatory conditions of the offering. Since this document announces a specific capital-raising event and details the terms of the share issuance, it falls under the category of 'Share Issue/Capital Change'.
2022-12-09 Finnish
Sisäpiiritieto: Optomed Oyj toteutti onnistuneesti suunnatun osakeannin keräten 4,1 miljoonaa euroa
Share Issue/Capital Change Classification · 99% confidence The document is a formal announcement from Optomed Oyj, dated December 9, 2022, detailing the successful completion of a directed share issue ('suunnattu osakeanti') to raise 4.1 million euros. The text explicitly discusses the issuance of new shares, the subscription price, the purpose (strengthening the balance sheet and funding growth strategy), and the expected registration and trading dates. This content directly relates to the company's capital structure and fundraising activities. Based on the definitions, the most appropriate classification is 'Capital/Financing Update' (CAP). It is not an Earnings Release (ER), Interim Report (IR), or a general Regulatory Filing (RNS), as it concerns a specific financing event.
2022-12-09 Finnish
Inside information: Optomed Plc successfully completes directed share issue raising EUR 4.1 million
Capital/Financing Update Classification · 98% confidence The document is an 'Inside information' announcement from Optomed Plc dated December 9, 2022, detailing the successful completion of a 'directed share issue' which raised EUR 4.1 million. This action involves issuing new shares to investors, which directly relates to the company's capital structure and fundraising activities. This fits the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a dividend notice (DIV). While it involves shares, it is a specific announcement about raising capital via a share issue, making CAP the most precise fit over SHA (Share Issue/Capital Change) or POS (Transaction in Own Shares), as the primary focus is the financing aspect and the proceeds raised. Given the content, CAP is the best classification.
2022-12-09 English
Arvopaperimarkkinalain 9 luvun 10 §:ssä tarkoitettu ilmoitus omistusosuuden muutoksesta
Major Shareholding Notification Classification · 100% confidence The document is a formal notification regarding a change in shareholding (liputusilmoitus) in accordance with Chapter 9, Section 10 of the Finnish Securities Markets Act. It details the percentage of shares and voting rights held by OP-Rahastoyhtiö Oy in Optomed Oyj. This type of disclosure is specifically categorized as a Major Shareholding Notification (MRQ).
2022-12-02 Finnish
Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings
Major Shareholding Notification Classification · 99% confidence The document is titled 'Optomed Oyj - Major shareholder announcements' and explicitly references 'Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings'. It details a change in the percentage of shares and voting rights held by a notifier (OP-Rahastoyhtiö Oy) due to a fund merger. This type of mandatory disclosure concerning changes in significant share ownership thresholds directly corresponds to the Major Shareholding Notification category. The document length (4270 chars) is substantial enough to be the primary filing, not just an announcement of a filing (ruling 2 does not apply). Therefore, the classification is Major Shareholding Notification (MRQ).
2022-12-02 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.